Rituxan rituximab: Pilot data; Phase II; marketed to treat low-grade non-Hodgkin's lymphoma (NHL)

In a 1-year study of 5 RA patients who had failed treatment with at least 5

Read the full 161 word article

How to gain access

Continue reading with a
two-week free trial.